Your browser doesn't support javascript.
loading
A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer.
Minemura, Hiroyuki; Yokouchi, Hiroshi; Azuma, Keisuke; Hirai, Ken-ichiro; Sekine, Satoko; Oshima, Kengo; Kanazawa, Kenya; Tanino, Yoshinori; Inokoshi, Yayoi; Ishii, Taeko; Katsuura, Yutaka; Oishi, Akio; Ishida, Takashi; Munakata, Mitsuru.
Afiliación
  • Minemura H; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. hiromine@fmu.ac.jp.
  • Yokouchi H; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. yokouchi@fmu.ac.jp.
  • Azuma K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. k-azuma@fmu.ac.jp.
  • Hirai K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. hirai-k@fmu.ac.jp.
  • Sekine S; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. sekine78ss@gmail.com.
  • Oshima K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. tohokunoichiro@yahoo.co.jp.
  • Kanazawa K; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. k-kenya@fmu.ac.jp.
  • Tanino Y; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. ytanino@fmu.ac.jp.
  • Inokoshi Y; Department of Pulmonary Medicine, Saiseikai Fukushima General Hospital, 25 Omori Aza Shimo-harada, Fukushima, 960-1101, Japan. inokoshi@fmu.ac.jp.
  • Ishii T; Department of Pulmonary Medicine, Saiseikai Fukushima General Hospital, 25 Omori Aza Shimo-harada, Fukushima, 960-1101, Japan. tae-i@fmu.ac.jp.
  • Katsuura Y; Department of Pulmonary Medicine, Saiseikai Fukushima General Hospital, 25 Omori Aza Shimo-harada, Fukushima, 960-1101, Japan. yutaka.yocchan@gmail.com.
  • Oishi A; Department of Thoracic Surgery, Fukushima Red Cross Hospital, 11-31 Irie-cho, Fukushima, 960-8530, Japan. ikyoku31@fukushima-med-jrc.jp.
  • Ishida T; Department of Pulmonary Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima, 960-1295, Japan. taku.ishida@nifty.ne.jp.
  • Munakata M; Clinical Oncology Center, Fukushima Medical University Hospital, 1 Hikariga-oka, Fukushima, 960-1295, Japan. taku.ishida@nifty.ne.jp.
BMC Res Notes ; 8: 220, 2015 Jun 05.
Article en En | MEDLINE | ID: mdl-26043909
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Receptores ErbB / Clorhidrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Res Notes Año: 2015 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Receptores ErbB / Clorhidrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Res Notes Año: 2015 Tipo del documento: Article País de afiliación: Japón